Evidence map›Paper›PMID 26085090›Full record

ArticleThe Journal of biological chemistry2015

Distortion of the Major Histocompatibility Complex Class I Binding Groove to Accommodate an Insulin-derived 10-Mer Peptide.

Chihiro Motozono, James A Pearson, Evy De Leenheer, Pierre J Rizkallah, Konrad Beck, Andrew Trimby, Andrew K Sewell, F Susan Wong, David K Cole

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 26 citations in OpenAlex.

  1. Review
  2. The pockets guide to HLA class I molecules.Biochemical Society transactions · 2021
    Review
  3. Review
  4. Article
  5. Circulating β cell-specific CD8Clinical and experimental immunology · 2020
    Article
  6. MHC-restricted Ag85B-specific CD8European journal of immunology · 2019
    Article
  7. Article
  8. Article
  9. Flipping out the peptide.Nature chemical biology · 2018
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 2 countries.

Chihiro MotozonoFrom the Division of Infection and Immunity and the Department of Immunology, Kinki University School of Medicine, Osaka 589-8511, Japan, and.
James A Pearsonthe Institute of Molecular and Experimental Medicine, Cardiff University School of Medicine, Heath Park, Cardiff CF14 4XN, United Kingdom.
Evy De Leenheerthe Institute of Molecular and Experimental Medicine, Cardiff University School of Medicine, Heath Park, Cardiff CF14 4XN, United Kingdom.
Pierre J RizkallahFrom the Division of Infection and Immunity and.
Konrad Beckthe Cardiff University School of Dentistry, Heath Park, Cardiff CF14 4XY, United Kingdom.
Andrew TrimbyFrom the Division of Infection and Immunity and.
Andrew K SewellFrom the Division of Infection and Immunity and.
F Susan Wongthe Institute of Molecular and Experimental Medicine, Cardiff University School of Medicine, Heath Park, Cardiff CF14 4XN, United Kingdom, wongfs@cf.ac.uk.
David K ColeFrom the Division of Infection and Immunity and coledk@cf.ac.uk.
Cardiff University · GB

Funding

Biotechnology and Biological Sciences Research Council BB/H001085/1Medical Research Council G0901155Wellcome Trust 100327Wellcome Trust WT095767
6 · The paper itself

Abstract

The non-obese diabetic mouse model of type 1 diabetes continues to be an important tool for delineating the role of T-cell-mediated destruction of pancreatic β-cells. However, little is known about the molecular mechanisms that enable this disease pathway. We show that insulin reactivity by a CD8(+) T-cell clone, known to induce type 1 diabetes, is characterized by weak T-cell antigen receptor binding to a relatively unstable peptide-MHC. The structure of the native 9- and 10-mer insulin epitopes demonstrated that peptide residues 7 and 8 form a prominent solvent-exposed bulge that could potentially be the main focus of T-cell receptor binding. The C terminus of the peptide governed peptide-MHC stability. Unexpectedly, we further demonstrate a novel mode of flexible peptide presentation in which the MHC peptide-binding groove is able to "open the back door" to accommodate extra C-terminal peptide residues.

Indexed as

Amino Acid SequenceAnimalsAntigen PresentationBinding SitesCD8-Positive T-LymphocytesCells, CulturedCrystallography, X-RayDiabetes Mellitus, Type 1Histocompatibility Antigens Class IInsulinMice, Inbred NODModels, MolecularPeptide FragmentsProtein BindingProtein Interaction Domains and MotifsHistocompatibility Antigens Class IInsulinPeptide Fragmentsbeta cellinsulinNOD mousepMHCT-cell receptor (TCR)type 1 diabetesx-ray crystallography

Identifiers

PMID26085090
PMCPMC4521012
OpenAlexW1852791087

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.